{"database": "lobbying", "table": "lobbying_activities", "rows": [[3184862, "6ebe4192-929a-4dd7-be2b-f387445d1b95", "Q2", "GOVERNMENT SOLUTIONS LLC", 401103251, "OTSUKA AMERICA PHARMACEUTICAL, INC.", 2024, "second_quarter", "HCR", "Mental Health, Brain Health, and Posttraumatic stress disorder (PTSD). Specifically health care policies relating to mental health and PTSD. Federal authorizations and appropriations issues related to mental health and PTSD.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2024-07-01T10:41:16-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3184862"], "units": {}, "query_ms": 0.39542606100440025, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}